↓ Skip to main content

Cochrane Database of Systematic Reviews

Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
111 Mendeley
Title
Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd009581.pub2
Pubmed ID
Authors

Guo Hua Zheng, Jian Ping Liu, Jian Feng Chu, Lijuan Mei, Hai Ying Chen

Abstract

Percutaneous coronary intervention (PCI) with stent placement is a standard treatment for coronary heart disease (CHD). In-stent restenosis after PCI remains an important clinical problem. Xiongshao capsule has been reported to be beneficial in preventing restenosis after PCI in CHD patients. However, the strength of evidence to support its use is unclear.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 14%
Student > Bachelor 15 14%
Researcher 13 12%
Student > Ph. D. Student 9 8%
Student > Doctoral Student 8 7%
Other 22 20%
Unknown 28 25%
Readers by discipline Count As %
Medicine and Dentistry 37 33%
Nursing and Health Professions 13 12%
Psychology 5 5%
Biochemistry, Genetics and Molecular Biology 4 4%
Unspecified 4 4%
Other 17 15%
Unknown 31 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2013.
All research outputs
#14,753,796
of 22,711,242 outputs
Outputs from Cochrane database of systematic reviews
#10,618
of 12,313 outputs
Outputs of similar age
#115,075
of 194,697 outputs
Outputs of similar age from Cochrane database of systematic reviews
#239
of 277 outputs
Altmetric has tracked 22,711,242 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,313 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,697 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 277 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.